 REDWOOD CITY, Calif., Nov. 10, 2021 GLOBE NEWSWIRE -- Biomea Fusion, Inc. Biomea Nasdaq: BMEA, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel irreversible small molecules to treat and improve the lives of patients with genetically defined cancers, today announced that Thomas Butler, Chief Executive Officer and Chairman of the Board, will participate in two upcoming virtual conferences. 